kythera biopharmaceuticals i
(KYTH:Consolidated Issue Listed on NASDAQ Global Select )
Jay Edward Birnbaum Ph.D.
|Age||Total Calculated Compensation||This person is connected to 45 board members in 5 different organizations across 8 different industries.|
See Board Relationships
Dr. Jay Edward Birnbaum, PhD, serves as a dermatology consultant specializing in ethical and OTC drugs, medical devices, and cosmeceuticals. Dr. Birnbaum Co-Founded Kythera Biopharmaceuticals and served its Chief Medical Officer. Dr. Birnbaum has 35 years of industry experience span the areas of discovery research, formulations, clinical R&D, regulatory and marketing, and he has been involved in the development and commercialization of numerous drug and consumer products ...
30930 Russell Ranch RoadPhone: 818-587-4500
Westlake Village, California 91362
Board Members Memberships*
Director and Member of Audit Committee
University of Wisconsin - Madison
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Peter J. Arduini||Chief Executive Officer, President, Director and Member of Special Award Committee|
Integra LifeSciences Holdings Corporation
|Olivier Bohuon||Chief Executive Officer, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination & Governance Committee |
Smith & Nephew plc
|Scott P. Anderson||Chairman, Chief Executive Officer and President|
Patterson Companies, Inc.
|Stanley M. Bergman||Executive Chairman and Chief Executive Officer|
Henry Schein, Inc.
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|¥182.0M||Compensation as of Fiscal Year 2014.|